According to T2 Biosystems 's latest financial reports the company's current revenue (TTM) is $7.19 M. In 2022 the company made a revenue of $22.3 M a decrease over the years 2021 revenue that were of $28.05 M.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $7.19 M | -67.75% |
2022 | $22.3 M | -20.5% |
2021 | $28.05 M | 54.76% |
2020 | $18.13 M | 117.52% |
2019 | $8.33 M | -20.62% |
2018 | $10.5 M | 125.03% |
2017 | $4.66 M | 14.39% |
2016 | $4.07 M | 45.06% |
2015 | $2.81 M | 2263.03% |
2014 | $0.11 M | -55.26% |
2013 | $0.26 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Aldeyra Therapeutics
ALDX | N/A | N/A | ๐บ๐ธ USA |
CareDx CDNA | $0.28 B | 3,797.18% | ๐บ๐ธ USA |